Can sleep disturbance in depression predict repetitive transcranial magnetic stimulation (rTMS) treatment response? 2013

Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
Homerton University Hospital NHS Foundation Trust, Homerton Row, London E9 6SR, United Kingdom.

Treatment for depression is not effective in all patients and it is therefore important to identify factors that can be used to tailor treatments. One potential factor is insomnia. Several repetitive transcranial magnetic stimulation (rTMS) studies have reported on this symptom, however, they did not take into account the presence of hypersomnia or that insomnia was related to their outcome measure. Our aim was to investigate whether baseline sleep disruption was related to rTMS treatment response. We pooled data from four clinical trials using rTMS to treat depression, including 139 subjects in data analysis. Insomnia was measured using the Hamilton Depression Rating Scale (HamD) sleep questions and hypersomnia from the Beck Depression Inventory (BDI). To reduce the possible impact of insomnia on our treatment response outcome we created an adjusted HamD score which omitted sleep items. Sleep disturbances were common in our study: 66% had insomnia and 38% hypersomnia. Using regression analysis with our adjusted HamD score we found no relation between baseline insomnia or hypersomnia and rTMS treatment response. Our data are consistent with previous studies; however, this is the first rTMS study to our knowledge that has attempted to dissociate baseline insomnia from the HamD outcome measure and to report no relationship between hypersomnia and rTMS outcome.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012893 Sleep Wake Disorders Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle. Sleep Disorders,Long Sleeper Syndrome,Short Sleep Phenotype,Short Sleeper Syndrome,Sleep-Related Neurogenic Tachypnea,Subwakefullness Syndrome,Disorder, Sleep,Disorder, Sleep Wake,Disorders, Sleep,Disorders, Sleep Wake,Long Sleeper Syndromes,Neurogenic Tachypnea, Sleep-Related,Neurogenic Tachypneas, Sleep-Related,Phenotype, Short Sleep,Phenotypes, Short Sleep,Short Sleep Phenotypes,Short Sleeper Syndromes,Sleep Disorder,Sleep Phenotypes, Short,Sleep Related Neurogenic Tachypnea,Sleep Wake Disorder,Sleep-Related Neurogenic Tachypneas,Sleeper Syndrome, Long,Sleeper Syndrome, Short,Sleeper Syndromes, Long,Sleeper Syndromes, Short,Subwakefullness Syndromes,Syndrome, Long Sleeper,Syndrome, Short Sleeper,Syndrome, Subwakefullness,Syndromes, Long Sleeper,Syndromes, Short Sleeper,Syndromes, Subwakefullness,Tachypnea, Sleep-Related Neurogenic,Tachypneas, Sleep-Related Neurogenic,Wake Disorder, Sleep,Wake Disorders, Sleep
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
January 2016, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
April 2009, Journal of vascular and interventional neurology,
Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
July 2003, Medizinische Monatsschrift fur Pharmazeuten,
Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
September 2021, Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,
Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
October 1995, Neuroreport,
Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
January 2017, Tijdschrift voor psychiatrie,
Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
January 2006, Supplements to Clinical neurophysiology,
Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
August 2015, Revue d'epidemiologie et de sante publique,
Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
February 2009, Bipolar disorders,
Alex Lowe, and Shantha M W Rajaratnam, and Kate Hoy, and John Taffe, and Paul B Fitzgerald
January 2007, L'Encephale,
Copied contents to your clipboard!